Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: A small randomized pilot trial

Annals of Vascular Surgery

Volumn 24, Issue 7, 2010, Pages 876-884

  Wang, Jue ^a   Zhu, Yue Qi ^a   Liu, Fang ^a   Li, Ming Hua ^a   Zhao, Jun Gong ^a   Tan, Hua Qiao ^a   Wang, Jian Bo ^a   Cheng, Ying Sheng ^b   Zhang, Pei Lei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; AMPUTATION; ANGIOPLASTY; ARTERY OCCLUSION; ARTERY REOCCLUSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; LIMB SALVAGE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SURGICAL TECHNIQUE;

AGED; AMPUTATION; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BATROXOBIN; CHINA; CONSTRICTION, PATHOLOGIC; DIABETIC ANGIOPATHIES; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PILOT PROJECTS; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 77956500331     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.03.030     Document Type: Article

References (21)

1. M. Schillinger, M. Exner, and W. Mlekusch Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis Radiology 225 2002 21 26
2. M. Schillinger, M. Haumer, and G. Schlerka Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation J Endovasc Ther 8 2001 477 483 (Pubitemid 33032462)
3. K.W. Johnston, M. Rae, and S.A. Hogg-Johnston Five-year results of a prospective study of percutaneous transluminal angioplasty Ann Surg 206 1987 403 413
4. J. Wang, Y.Q. Zhu, and J.G. Zhao Infrapopliteal angioplasty with a long over-the-wire (OTW) balloon in the treatment of severe limb ischemia in diabetic patients: a retrospective study Acta Radiol 50 2009 360 367
5. Y.Q. Zhu, J.G. Zhao, and F. Liu Subintimal angioplasty for below-the-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia J Endovasc Ther 16 2009 604 612
6. O. Iida, S. Nanto, and M. Uematsu Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery Circ J 69 2005 1256 1259
7. K. Mannava, and S.R. Money Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions Am J Cardiovasc Drugs 7 2007 59 66
8. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
9. M. Alessandro Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks Circulation 101 2000 744 750
10. J.A. Páramo, O. Beloqui, C. Roncal, A. Benito, and J. Orbe Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease Haematologica 89 2004 1226 1231 (Pubitemid 39390448)
11. O. Schlager, M. Francesconi, and M. Haumer Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a "real-world" setting J Endovasc Ther 14 2007 452 459
12. D.J. Spinosa, D.A. Leung, and A.H. Matsumoto Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia Radiology 232 2004 499 507
13. A.M. Perchuć, L. Menin, and R. Stocklin The potential of Bothrops moojeni venom in the field of hemostasis. Established use and new insights Pathophysiol Haemost Thromb 34 2005 241 245
14. H.Y. Tang, X.Y. Wu, and F.D. Wang Changes of plasma d-dimer and fibrinogen in patients with lacunar cerebral infarction after treatment with batroxobin: a comparative analysis Acad J PLA Postgrad Med Sch 30 2009 148 149
15. M. Thor, A. Yu, and J. Swedenborg Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia Thromb Res 105 2002 379 383
16. M. Schillinger, M. Exner, and W. Mlekusch Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries Thromb Haemost 87 2002 959 965
17. H. Kawano, T. Tomaru, and M. Omata Adjunctive Therapy with an Antithrombotic Drug Can Prevent Reocclusion and Induce Residual Thrombus Reduction After Percutaneous Transcatheter Angioplasty of the Thrombotic Lesions J Thromb Thrombolysis 4 1997 293 300
18. T. Ugarova, and V.P. Yakubenko Recognition of fibrinogen by leukocyte integrins Ann NY Acad Sci 936 2001 369 384
19. R.L. Wilensky, K.L. March, and I. Gradus-Pizlu Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit Circulation 92 1995 2995 3005
20. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
21. D. Michalskia, L. Küppers-Tiedta, and C. Weise Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats Brain Res 1303 2009 161 168